In assays employing MCF-7 breast cancer cells overexpressing MMP-9, the MMP-9-selective N-TIMP-2 was uniquely capable of blocking gelatin degradation and inhibiting cellular migration. This evidence concerns the gene MMP9 and breast carcinoma.